Showing results (91-100 of 6,269) with videos related to
Sort By:
Pageof 627
Diabetes, Obesity & Metabolism|December 31, 2013
Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitusG B Bolli, D R OwensDiabetes, Obesity & Metabolism|December 31, 2013
Is statin-induced diabetes clinically relevant? A comprehensive review of the literatureD S H Bell, J J DiNicolantonio, J H O'KeefeDiabetes, Obesity & Metabolism|August 27, 2014
Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonist albiglutide (HARMONY 1 trial): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes mellitus not controlled on pioglitazone, with or without metforminJ Reusch, M W Stewart, C M Perkins, et al.Diabetes, Obesity & Metabolism|August 28, 2014
New treatments for diabetic retinopathyA Das, S Stroud, A Mehta, et al.Diabetes, Obesity & Metabolism|April 22, 2016
Interchangeability among reference insulin analogues and their biosimilars: regulatory framework, study design and clinical implicationsH A Dowlat, M K Kuhlmann, H Khatami, et al.Diabetes, Obesity & Metabolism|June 29, 2016
Basal insulin peglispro versus insulin glargine in insulin-naïve type 2 diabetes: IMAGINE 2 randomized trialM J Davies, D Russell-Jones, J-L Selam, et al.Diabetes, Obesity & Metabolism|October 29, 2015
Hypoglycaemia after gastric bypass: mechanisms and treatmentP Ritz, C Vaurs, M Barigou, et al.Diabetes, Obesity & Metabolism|October 6, 2015
Effect of high-dose atorvastatin on the cardiovascular risk associated with individual components of metabolic syndrome: a subanalysis of the Treating to New Targets (TNT) studyP C Deedwania, J Shepherd, A Breazna, et al.Diabetes, Obesity & Metabolism|October 6, 2015
Evaluation of immunogenicity of LY2963016 insulin glargine compared with Lantus® insulin glargine in patients with type 1 or type 2 diabetes mellitusL L Ilag, M A Deeg, T Costigan, et al.Diabetes, Obesity & Metabolism|October 6, 2015
Glucagon increases energy expenditure independently of brown adipose tissue activation in humansV Salem, C Izzi-Engbeaya, C Coello, et al.Pageof 627